From the Editor-in-Chief’s Desk: Challenges and Opportunities for the Assessment of Complex Neurodevelopmental Phenotypes

Abstract

Get full access to this article

View all access options for this article.

References

Chu

, Ince

. Collaborating with applied behavior analysis teams to optimize telehealth pharmacologic management of catatonia in nonverbal youth with autism spectrum disorder. J Child Adolesc Psychopharmacol, 2025; 35(6):365–368; doi: 10.1089/cap.2025.0021

Cuellar

, Henry

, Smith

, et al. Strategies to facilitate intravenous access for electroconvulsive therapy procedures in pediatric and neurodivergent patients: A case series. J Child Adolesc Psychopharmacol, 2025; 35(7):431–435; doi: 10.1089/cap.2025.0031

Fitzpatrick

, Antony

, Nurmi

, et al. Review: Child psychiatry in the era of genomics: The promise of translational genetics research for the clinic. JAACAP Open, 2025; 3(2):157–170; doi: 10.1016/j.jaacop.2024.06.002

Glasson

, Buckley

, Chen

, et al. Systematic review and meta-analysis: Mental health in children with neurogenetic disorders associated with intellectual disability. J Am Acad Child Adolesc Psychiatry, 2020; 59(9):1036–1048; doi: 10.1016/j.jaac.2020.01.006

Kaat

, Evans

, Nili

, et al. Vineland-3 growth scale values: Psychometric properties for clinical trial readiness in SCN2A. J Child Adolesc Psychopharmacol, 2025; 35(7):416–423; doi: 10.1089/cap.2024.0107

Kaufmann

, Oberman

, Downs

, et al. Rett Syndrome Behaviour Questionnaire: Variability of scores and related factors. J Child Adolesc Psychopharmacol, 2025; 35(7):388–398; doi: 10.1089/cap.2024.0128

Oberman

, Berry-Kravis

, Budimirovic

, et al. The Aberrant Behavior Checklist for Fragile X syndrome: A qualitative clinician evaluation of content validity. J Child Adolesc Psychopharmacol, 2025; 35(7):399–415; doi: 10.1089/cap.2024.0147

Paik

, Hauptman

. Letter: Extended-release lorazepam as a safe and effective option for treating catatonia in an individual with Down syndrome. J Child Adolesc Psychopharmacol, 2025; 35(7):436–437; doi: 10.1089/cap.2025.0061

Saito

, Nikolov

, Sorter

, et al. Systematic search and review: Management and prevention of agitation and aggression in the child and adolescent psychiatric inpatient setting. J Child Adolesc Psychopharmacol, 2025; 35(7):375–387; doi: 10.1089/cap.2025.0043

10.

Smith

, Sengstack

, McCoy

, et al. High frequency utilization of the outpatient messaging system in a specialized outpatient catatonia clinic for individuals with autism spectrum disorder. J Child Adolesc Psychopharmacol, 2025; 35(7):424–430; doi: 10.1089/cap.2025.0034

11.

Thom

, Warren

, Khan

, et al. A blueprint for translational precision medicine in autism spectrum disorder and related neurogenetic syndromes. J Child Adolesc Psychopharmacol, 2025; 35(4):178–193; doi: 10.1089/cap.2025.0023